Note*: This report requires 7-10 business days to complete.
Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Non-Hodgkin’s Lymphoma (NHL) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Non-Hodgkin’s Lymphoma (NHL) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Non-Hodgkin’s Lymphoma (NHL) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Non-Hodgkin’s Lymphoma (NHL) market.
• Identifying patient populations in the global “Non-Hodgkin’s Lymphoma (NHL) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Non-Hodgkin’s Lymphoma (NHL) therapeutics in each of the markets covered.
• To understand the future market competition in the global Non-Hodgkin’s Lymphoma (NHL) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Non-Hodgkin’s Lymphoma (NHL) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Non-Hodgkin’s Lymphoma (NHL) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Non-Hodgkin’s Lymphoma (NHL) Market
• Global Epidemiology of Non-Hodgkin’s Lymphoma (NHL) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Non-Hodgkin’s Lymphoma (NHL) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Non-Hodgkin’s Lymphoma (NHL) (2013-2023)
• Table 7: Non-Hodgkin’s Lymphoma (NHL) Global Market (USD Millions), (2013-2015)
• Table 8: Non-Hodgkin’s Lymphoma (NHL) Global Market (USD Millions), (2016-2023)
• Table 9: Non-Hodgkin’s Lymphoma (NHL) US Market (USD Millions), (2013-2015)
• Table 10: Non-Hodgkin’s Lymphoma (NHL) US Market (USD Millions), (2016-2023)
• Table 11: Non-Hodgkin’s Lymphoma (NHL) Germany Market (USD Millions), (2013-2015)
• Table 12: Non-Hodgkin’s Lymphoma (NHL) Germany Market (USD Millions), (2016-2023)
• Table 13: Non-Hodgkin’s Lymphoma (NHL) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Non-Hodgkin’s Lymphoma (NHL) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Non-Hodgkin’s Lymphoma (NHL) France Market (USD Millions), (2013-2015)
• Table 16: Non-Hodgkin’s Lymphoma (NHL) France Market (USD Millions), (2016-2023)
• Table 17: Non-Hodgkin’s Lymphoma (NHL) Italy Market (USD Millions), (2013-2015)
• Table 18: Non-Hodgkin’s Lymphoma (NHL) Italy Market (USD Millions), (2016-2023)
• Table 19: Non-Hodgkin’s Lymphoma (NHL) Spain Market (USD Millions), (2013-2015)
• Table 20: Non-Hodgkin’s Lymphoma (NHL) Spain Market (USD Millions), (2016-2023)
• Table 21: Non-Hodgkin’s Lymphoma (NHL) Japan Market (USD Millions), (2013-2015)
• Table 22: Non-Hodgkin’s Lymphoma (NHL) Japan Market (USD Millions), (2016-2023)
• Table 23: Non-Hodgkin’s Lymphoma (NHL) ROW Market (USD Millions), (2013-2015)
• Table 24: Non-Hodgkin’s Lymphoma (NHL) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Non-Hodgkin’s Lymphoma (NHL) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Non-Hodgkin’s Lymphoma (NHL) (2013-2023)
• Figure 3: Non-Hodgkin’s Lymphoma (NHL) Global Market (USD Millions), (2013-2015)
• Figure 4: Non-Hodgkin’s Lymphoma (NHL) Global Market (USD Millions), (2016-2023)
• Figure 5: Non-Hodgkin’s Lymphoma (NHL) US Market (USD Millions), (2013-2015)
• Figure 6: Non-Hodgkin’s Lymphoma (NHL) US Market (USD Millions), (2016-2023)
• Figure 7: Non-Hodgkin’s Lymphoma (NHL) Germany Market (USD Millions), (2013-2015)
• Figure 8: Non-Hodgkin’s Lymphoma (NHL) Germany Market (USD Millions), (2016-2023)
• Figure 9: Non-Hodgkin’s Lymphoma (NHL) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Non-Hodgkin’s Lymphoma (NHL) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Non-Hodgkin’s Lymphoma (NHL) France Market (USD Millions), (2013-2015)
• Figure 12: Non-Hodgkin’s Lymphoma (NHL) France Market (USD Millions), (2016-2023)
• Figure 13: Non-Hodgkin’s Lymphoma (NHL) Italy Market (USD Millions), (2013-2015)
• Figure 14: Non-Hodgkin’s Lymphoma (NHL) Italy Market (USD Millions), (2016-2023)
• Figure 15: Non-Hodgkin’s Lymphoma (NHL) Spain Market (USD Millions), (2013-2015)
• Figure 16: Non-Hodgkin’s Lymphoma (NHL) Spain Market (USD Millions), (2016-2023)
• Figure 17: Non-Hodgkin’s Lymphoma (NHL) Japan Market (USD Millions), (2013-2015)
• Figure 18: Non-Hodgkin’s Lymphoma (NHL) Japan Market (USD Millions), (2015-2023)
• Figure 19: Non-Hodgkin’s Lymphoma (NHL) ROW Market (USD Millions), (2013-2015)
• Figure 20: Non-Hodgkin’s Lymphoma (NHL) ROW Market (USD Millions), (2016-2023)
• Market (7MM)
• Market forecasting
• Sales forecasting
• Market segments
• Pipeline products and technologies
• Competitive landscape
• SWOT analysis
